Quote
—
—
No scored catalysts in the window yet.
Market cap
—
P/E
—
EPS
—
Beta
—
52W range
—
Day range
—
Open
—
Prev close
—
Volume
—
Avg volume
—
Dividend
—
IPO
—
https://www.globenewswire.com/news-release/2026/08/21/3348995/0/en/pharmala-biotech-provides-corporate-update-u-s-patent-granted-covering-novel-enantioselective-processes-decision-on-apa-01-and-engagement-of-canaccord-genuity-as-exclusive-investme.html · 8/21/2026+0.80
https://www.globenewswire.com/news-release/2026/02/23/3242630/0/en/PharmAla-To-Supply-Amsterdam-UMC-with-LaNeo-MDMA-Including-Development-of-New-Single-Capsule-Stability-Data.html · 2/23/2026+0.80
https://www.globenewswire.com/news-release/2025/11/03/3179275/0/en/PharmAla-Files-Final-Base-Shelf-Prospectus-and-Signs-Term-Sheet-with-Radium-Capital.html · 11/3/2025+0.60
https://www.globenewswire.com/news-release/2025/09/25/3156391/0/en/PharmAla-Partners-with-Veridion-Group-as-Exclusive-Distributor-in-New-Zealand.html · 9/25/2025
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works